Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,476,644 papers from all fields of science
Search
Sign In
Create Free Account
Anti-PD-1 Monoclonal Antibody REGN2810
Known as:
REGN2810
A human monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1, PCD-1) protein…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
NCIt Antineoplastic Agent Terminology
antigen binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Cemiplimab (REGN2810), a Fully Human Anti-PD-1 Monoclonal Antibody, for Patients with Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: Initial Safety and Efficacy from…
K. Papadopoulos
,
T. Owonikoko
,
+17 authors
J. Homsi
2018
Corpus ID: 80560914
Abstract not available. Disclosures: Study sponsored by Regeneron Pharmaceuticals Inc. and Sanofi. Copyright 2018 SKIN